ID: ALA3309927

Max Phase: Preclinical

Molecular Formula: C16H15N

Molecular Weight: 221.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)c1ccc(C#Cc2ccccc2)cc1

Standard InChI:  InChI=1S/C16H15N/c1-17(2)16-12-10-15(11-13-16)9-8-14-6-4-3-5-7-14/h3-7,10-13H,1-2H3

Standard InChI Key:  WBLCYYFORJVCJV-UHFFFAOYSA-N

Associated Targets(Human)

LS174T 446 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 221.30Molecular Weight (Monoisotopic): 221.1204AlogP: 3.15#Rotatable Bonds: 1
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.78CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.67Np Likeness Score: -0.98

References

1. Sviripa VM, Zhang W, Kril LM, Liu AX, Yuan Y, Zhan CG, Liu C, Watt DS..  (2014)  Halogenated diarylacetylenes repress c-myc expression in cancer cells.,  24  (15): [PMID:24930834] [10.1016/j.bmcl.2014.04.113]

Source